Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia.

Abstract:

:Bacterial coinfection in COVID-19 patients has the potential to complicate treatments and accelerate the development of antibiotic resistance in the clinic due to the widespread use of broad-spectrum antibiotics, including in Indonesia. The surge of COVID-19 patients may worsen antibiotic overuse; therefore, information on the actual extent of bacterial coinfection in COVID-19 patients in Indonesia is crucial to inform appropriate treatment. This Viewpoint elaborates on a nascent research project focused on sequencing of swab samples to detect bacterial coinfection in COVID-19 patients in Indonesia. Supported by a L'Oréal-UNESCO For Women in Science National Fellowship, it is designed to inform better clinical management of COVID-19 in Indonesia.

journal_name

ACS Infect Dis

journal_title

ACS infectious diseases

authors

Prasetyoputri A

doi

10.1021/acsinfecdis.1c00006

subject

Has Abstract

pub_date

2021-01-27 00:00:00

issn

2373-8227

pub_type

杂志文章
  • Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.

    abstract::The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章,评审

    doi:10.1021/acsinfecdis.0c00052

    authors: Xu J,Shi PY,Li H,Zhou J

    更新日期:2020-05-08 00:00:00

  • Antituberculosis Activity of the Antimalaria Cytochrome bcc Oxidase Inhibitor SCR0911.

    abstract::The ability to respire and generate adenosine triphosphate (ATP) is essential for the physiology, persistence, and pathogenicity of Mycobacterium tuberculosis, which causes tuberculosis. By employing a lead repurposing strategy, the malarial cytochrome bc1 inhibitor SCR0911 was tested against mycobacteria. Docking stu...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.9b00408

    authors: Chong SMS,Manimekalai MSS,Sarathy JP,Williams ZC,Harold LK,Cook GM,Dick T,Pethe K,Bates RW,Grüber G

    更新日期:2020-04-10 00:00:00

  • Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist.

    abstract::Stimulator of interferon genes (STING) is an integral ER-membrane protein that can be activated by 2'3'-cGAMP synthesized by cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) upon binding of double-stranded DNA. It activates interferon (IFN) and inflammatory cytokine responses to defend against in...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.9b00010

    authors: Zhang X,Liu B,Tang L,Su Q,Hwang N,Sehgal M,Cheng J,Ma J,Zhang X,Tan Y,Zhou Y,Duan Z,DeFilippis VR,Viswanathan U,Kulp J,Du Y,Guo JT,Chang J

    更新日期:2019-07-12 00:00:00

  • Nerve Growth Factor Confers Neuroprotection against Colistin-Induced Peripheral Neurotoxicity.

    abstract::Neurotoxicity is an unwanted side effect for patients when receiving parenteral colistin therapy. The development of effective neuroprotective agents that can be coadministered during colistin therapy remains a priority area in antimicrobial chemotherapy. The present study aimed to investigate the protective effect of...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00107

    authors: Dai C,Xiong J,Wang Y,Shen J,Velkov T,Xiao X

    更新日期:2020-06-12 00:00:00

  • An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.

    abstract::Novel combination therapies are desperately needed for combating lung infections caused by bacterial "superbugs". This study aimed to investigate the synergistic antibacterial activity of polymyxin B in combination with the cystic fibrosis (CF) drugs KALYDECO (ivacaftor) and ORKAMBI (ivacaftor + lumacaftor) against Gr...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.6b00035

    authors: Schneider EK,Azad MA,Han ML,Tony Zhou Q,Wang J,Huang JX,Cooper MA,Doi Y,Baker MA,Bergen PJ,Muller MT,Li J,Velkov T

    更新日期:2016-07-08 00:00:00

  • A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

    abstract::4-Oxo-4-phenyl-but-2-enoates inhibit MenB, the 1,4-dihydroxyl-2-naphthoyl-CoA synthase in the bacterial menaquinone (MK) biosynthesis pathway, through the formation of an adduct with coenzyme A (CoA). Here, we show that the corresponding methyl butenoates have MIC values as low as 0.35-0.75 µg/mL against drug sensitiv...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.6b00023

    authors: Matarlo JS,Lu Y,Daryaee F,Daryaee T,Ruzsicska B,Walker SG,Tonge PJ

    更新日期:2016-05-13 00:00:00

  • Targeting Bacterial Sortase A with Covalent Inhibitors: 27 New Starting Points for Structure-Based Hit-to-Lead Optimization.

    abstract::Because of its essential role as a bacterial virulence factor, enzyme sortase A (SrtA) has become an attractive target for the development of new antivirulence drugs against Gram-positive infections. Here we describe 27 compounds identified as covalent inhibitors of Staphylococcus aureus SrtA by screening a library of...

    journal_title:ACS infectious diseases

    pub_type: 信件

    doi:10.1021/acsinfecdis.9b00265

    authors: Jaudzems K,Kurbatska V,Je Kabsons A,Bobrovs R,Rudevica Z,Leonchiks A

    更新日期:2020-02-14 00:00:00

  • Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery.

    abstract::Although many new anti-infectives have been discovered and developed solely using phenotypic cellular screening and assay optimization, most researchers recognize that structure-guided drug design is more practical and less costly. In addition, a greater chemical space can be interrogated with structure-guided drug de...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章,评审

    doi:10.1021/acsinfecdis.7b00276

    authors: Luth MR,Gupta P,Ottilie S,Winzeler EA

    更新日期:2018-03-09 00:00:00

  • Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry.

    abstract::Coronaviruses first garnered widespread attention in 2002 when the severe acute respiratory syndrome coronavirus (SARS-CoV) emerged from bats in China and rapidly spread in human populations. Since then, Middle East respiratory syndrome coronavirus (MERS-CoV) emerged and still actively infects humans. The recent SARS-...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00491

    authors: Firpo MR,Mastrodomenico V,Hawkins GM,Prot M,Levillayer L,Gallagher T,Simon-Loriere E,Mounce BC

    更新日期:2020-10-06 00:00:00

  • Inhibition of Biofilm Formation by Candida albicans and Polymicrobial Microorganisms by Nepodin via Hyphal-Growth Suppression.

    abstract::Candida albicans is an opportunistic pathogenic yeast and is responsible for candidiasis. It readily colonizes host tissues and implant devices, and forms biofilms, which play an important role in pathogenesis and drug resistance. In this study, the antibiofilm, antihyphal, and antivirulence activities of nepodin, iso...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.9b00033

    authors: Lee JH,Kim YG,Khadke SK,Yamano A,Watanabe A,Lee J

    更新日期:2019-07-12 00:00:00

  • Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio.

    abstract::Malaria remains a major global health problem. In 2015 alone, more than 200 million cases of malaria were reported, and more than 400,000 deaths occurred. Since 2010, emerging resistance to current front-line ACTs (artemisinin combination therapies) has been detected in endemic countries. Therefore, there is an urgenc...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.7b00211

    authors: Chaparro MJ,Calderón F,Castañeda P,Fernández-Alvaro E,Gabarró R,Gamo FJ,Gómez-Lorenzo MG,Martín J,Fernández E

    更新日期:2018-04-13 00:00:00

  • Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells.

    abstract::The fusion between the viral and the target cell membrane is a crucial step in the life cycle of enveloped viruses. The blocking of this process is a well-known therapeutic approach that led to the development of the fusion inhibitor peptide enfuvirtide, clinically used against human immunodeficiency virus (HIV) type ...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.8b00321

    authors: Gomes B,Sanna G,Madeddu S,Hollmann A,Santos NC

    更新日期:2019-04-12 00:00:00

  • Zika Virus: Diagnosis, Therapeutics, and Vaccine.

    abstract::The current explosive epidemic of Zika virus in South and Central America, as well as the Caribbean, poses a global public health emergency. Here we comment on the challenges on development of better diagnosis and potential therapeutics and vaccine for Zika virus. ...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.6b00030

    authors: Shan C,Xie X,Barrett AD,Garcia-Blanco MA,Tesh RB,Vasconcelos PF,Vasilakis N,Weaver SC,Shi PY

    更新日期:2016-03-11 00:00:00

  • Developments in Glycopeptide Antibiotics.

    abstract::Glycopeptide antibiotics (GPAs) are a key weapon in the fight against drug resistant bacteria, with vancomycin still a mainstream therapy against serious Gram-positive infections more than 50 years after it was first introduced. New, more potent semisynthetic derivatives that have entered the clinic, such as dalbavanc...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.7b00258

    authors: Blaskovich MAT,Hansford KA,Butler MS,Jia Z,Mark AE,Cooper MA

    更新日期:2018-05-11 00:00:00

  • Proof-of-Concept Rapid Diagnostic Test for Onchocerciasis: Exploring Peptide Biomarkers and the Use of Gold Nanoshells as Reporter Nanoparticles.

    abstract::Three O. volvulus immunogenic peptide sequences recently discovered by peptide microarray were adapted to a lateral flow assay (LFA). The LFA employs gold nanoshells as novel high-contrast reporter nanoparticles and detects a serological response against the 3 peptides, found in OvOC9384, OvOC198, and OvOC5528, respec...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.8b00031

    authors: Gonzalez-Moa MJ,Van Dorst B,Lagatie O,Verheyen A,Stuyver L,Biamonte MA

    更新日期:2018-06-08 00:00:00

  • Investigations into the Antibacterial Mechanism of Action of Viridicatumtoxins.

    abstract::Viridicatumtoxins are a rare class of tetracycline-like antibiotics that strongly inhibit drug-resistant Gram-positive bacteria. Although reported to exhibit in vitro inhibition activity to undecaprenyl pyrophosphate synthase (UPPS), an essential enzyme in bacterial cell wall synthesis, the biological targets and mech...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00031

    authors: Li W,Li L,Zhang C,Cai Y,Gao Q,Wang F,Cao Y,Lin J,Li J,Shang Z,Lin W

    更新日期:2020-07-10 00:00:00

  • Systematic Analysis of Structure Similarity between Zika Virus and Other Flaviviruses.

    abstract::Zika virus (ZIKV) infection has caused global concern because of its association with fetal microcephaly and serious neurological complications in adults since 2016. Currently, no specific anti-ZIKV therapy is available to control ZIKV infection. During the last couple of years, the intensive investigation of ZIKV str...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章,评审

    doi:10.1021/acsinfecdis.9b00047

    authors: Hu Y,Sun L

    更新日期:2019-07-12 00:00:00

  • Photodynamic Inactivation of ESKAPE Group Bacterial Pathogens in Planktonic and Biofilm Cultures Using Metallated Porphyrin-Doped Conjugated Polymer Nanoparticles.

    abstract::Photodynamic inactivation (PDI) protocols using photoactive metallated porphyrin-doped conjugated polymer nanoparticles (CPNs) and blue light were developed to eliminate multidrug-resistant pathogens. CPNs-PDI protocols using varying particle concentrations and irradiation doses were tested against nine pathogenic bac...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00268

    authors: Martínez SR,Ibarra LE,Ponzio RA,Forcone MV,Wendel AB,Chesta CA,Spesia MB,Palacios RE

    更新日期:2020-08-14 00:00:00

  • Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.

    abstract::Chronic hepatitis B virus (HBV) infection remains a major cause of morbidity and mortality worldwide. HBV surface antigen loss is considered a functional cure and is an ideal goal for antiviral therapy. However, current treatment regimens, including nucleos(t)ide analogues or interferons monotherapy and combination th...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章,评审

    doi:10.1021/acsinfecdis.8b00297

    authors: Zhu W,Liu H,Zhang X

    更新日期:2019-05-10 00:00:00

  • Biochemical Characterization of Respiratory Syncytial Virus RNA-Dependent RNA Polymerase Complex.

    abstract::RNA-dependent RNA polymerases (RdRPs) from nonsegmented negative strand (NNS) RNA viruses perform both mRNA transcription and genome replication, and these activities are regulated by their interactions with RNA and other accessory proteins within the ribonucleoprotein (RNP) complex. Detailed biochemical characterizat...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00554

    authors: Balakrishnan A,Price E,Luu C,Shaul J,Wartchow C,Cantwell J,Vo T,DiDonato M,Spraggon G,Hekmat-Nejad M

    更新日期:2020-10-09 00:00:00

  • Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis.

    abstract::MmpL3, an essential mycolate transporter in the inner membrane of Mycobacterium tuberculosis (Mtb), has been identified as a target of multiple, chemically diverse antitubercular drugs. However, several of these molecules seem to have secondary targets and inhibit bacterial growth by more than one mechanism. Here, we ...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00675

    authors: Grover S,Engelhart CA,Pérez-Herrán E,Li W,Abrahams KA,Papavinasasundaram K,Bean JM,Sassetti CM,Mendoza-Losana A,Besra GS,Jackson M,Schnappinger D

    更新日期:2021-01-08 00:00:00

  • Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.

    abstract::Metallo-β-lactamases (MBLs) are a growing threat to the continued efficacy of β-lactam antibiotics. Recently, aspergillomarasmine A (AMA) was identified as an MBL inhibitor, but the mode of inhibition was not fully characterized. Equilibrium dialysis and metal analysis studies revealed that 2 equiv of AMA effectively ...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.7b00106

    authors: Bergstrom A,Katko A,Adkins Z,Hill J,Cheng Z,Burnett M,Yang H,Aitha M,Mehaffey MR,Brodbelt JS,Tehrani KHME,Martin NI,Bonomo RA,Page RC,Tierney DL,Fast W,Wright GD,Crowder MW

    更新日期:2018-02-09 00:00:00

  • Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral Susceptibility.

    abstract::Glycosylated proteins (i.e., mucins, IgG) are important mediators of innate antiviral immunity in the vagina; however, our current knowledge of the role that glycan themselves play in genital immunity is relatively low. Herein, we evaluate the relationship between innate antiviral immunity and glycomic composition in ...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章,随机对照试验

    doi:10.1021/acsinfecdis.8b00157

    authors: Koppolu S,Wang L,Mathur A,Nigam JA,Dezzutti CS,Isaacs C,Meyn L,Bunge KE,Moncla BJ,Hillier SL,Rohan LC,Mahal LK

    更新日期:2018-11-09 00:00:00

  • Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19.

    abstract::In December 2019, a novel beta (β) coronavirus eventually named SARS-CoV-2 emerged in Wuhan, Hubei province, China, causing an outbreak of severe and even fatal pneumonia in humans. The virus has spread very rapidly to many countries across the world, resulting in the World Health Organization (WHO) to declare a pande...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章,评审

    doi:10.1021/acsinfecdis.0c00274

    authors: da Silva SJR,Silva CTAD,Guarines KM,Mendes RPG,Pardee K,Kohl A,Pena L

    更新日期:2020-09-11 00:00:00

  • Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein-Fusion Combination Vaccine.

    abstract::Subunit vaccines composed of protein antigens covalently attached to Toll-like receptor (TLR) agonists elicit superior immune responses compared to mixtures of antigens and TLR agonists. Among different conjugation approaches, enzyme-mediated ligation is one of the few that provides an opportunity for the generation o...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00047

    authors: Xu Z,Rivera-Hernandez T,Moyle PM

    更新日期:2020-07-10 00:00:00

  • Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant.

    abstract::Antibacterial adjuvants are of great significance, since they allow the therapeutic dose of conventional antibiotics to be lowered and reduce the insurgence of antibiotic resistance. Herein, we report that an O-acetylserine sulfhydrylase (OASS) inhibitor can be used as a colistin adjuvant to treat infections caused by...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00378

    authors: Annunziato G,Spadini C,Franko N,Storici P,Demitri N,Pieroni M,Flisi S,Rosati L,Iannarelli M,Marchetti M,Magalhaes J,Bettati S,Mozzarelli A,Cabassi CS,Campanini B,Costantino G

    更新日期:2021-01-29 00:00:00

  • Targeted Inhibition of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 with a Constrained J Domain-Derived Disruptor Peptide.

    abstract::To explore the possibility of constrained peptides to target Plasmodium-infected cells, we designed a J domain mimetic derived from Plasmodium falciparum calcium-dependent protein kinase 1 ( PfCDPK1) as a strategy to disrupt J domain binding and inhibit PfCDPK1 activity. The J domain disruptor (JDD) peptide was confor...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.8b00347

    authors: Flaherty BR,Ho TG,Schmidt SH,Herberg FW,Peterson DS,Kennedy EJ

    更新日期:2019-04-12 00:00:00

  • Protein S-Palmitoylation Is Responsive to External Signals and Plays a Regulatory Role in Microneme Secretion in Plasmodium falciparum Merozoites.

    abstract::Protein S-palmitoylation is an important post-translational modification (PTM) in blood stages of the malaria parasite, Plasmodium falciparum. S-palmitoylation refers to reversible covalent modification of cysteine residues of proteins by saturated fatty acids. In vivo, palmitoylation is regulated by concerted activit...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.9b00321

    authors: Siddiqui MA,Singh S,Malhotra P,Chitnis CE

    更新日期:2020-03-13 00:00:00

  • JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo.

    abstract::Flaviviruses causes significant human disease. Recent outbreaks of the Zika virus highlight the need to develop effective therapies for this class of viruses. Previously we identified niclosamide as a broad-spectrum inhibitor for flaviviruses by targeting the interface between viral protease NS3 and its cofactor NS2B....

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.0c00217

    authors: Li Z,Xu J,Lang Y,Fan X,Kuo L,D'Brant L,Hu S,Samrat SK,Trudeau N,Tharappel AM,Rugenstein N,Koetzner CA,Zhang J,Chen H,Kramer LD,Butler D,Zhang QY,Zhou J,Li H

    更新日期:2020-10-09 00:00:00

  • Daptomycin Pore Formation Is Restricted by Lipid Acyl Chain Composition.

    abstract::Daptomycin is a calcium-dependent lipopeptide antibiotic that is used clinically against various Gram-positive pathogens. It acts on bacterial cell membranes, whose susceptibility varies with the content of phosphatidylglycerol (PG). Some studies have reported that daptomycin permeabilizes and depolarizes bacterial ce...

    journal_title:ACS infectious diseases

    pub_type: 杂志文章

    doi:10.1021/acsinfecdis.7b00138

    authors: Taylor R,Beriashvili D,Taylor S,Palmer M

    更新日期:2017-11-10 00:00:00